These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23433456)

  • 21. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
    Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
    Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SDZ MRL 953, a lipid A analog as selective cytokine inducer.
    Stern A; Engelhardt R; Foster C; Golenbock D; Hildebrandt J; Landmann R; Mayer P; Stütz P
    Prog Clin Biol Res; 1995; 392():549-65. PubMed ID: 8524963
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity.
    Dowling QM; Sivananthan SJ; Guderian JA; Moutaftsi M; Chesko JD; Fox CB; Vedvick TS; Kramer RM
    J Pharm Sci; 2014 Mar; 103(3):879-89. PubMed ID: 24464844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa.
    Muroi M; Tanamoto K
    J Biol Chem; 2006 Mar; 281(9):5484-91. PubMed ID: 16407172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MPL Adjuvant Contains Competitive Antagonists of Human TLR4.
    Wang YQ; Bazin-Lee H; Evans JT; Casella CR; Mitchell TC
    Front Immunol; 2020; 11():577823. PubMed ID: 33178204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.
    Delude RL; Savedra R; Zhao H; Thieringer R; Yamamoto S; Fenton MJ; Golenbock DT
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9288-92. PubMed ID: 7568119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.
    Walsh C; Gangloff M; Monie T; Smyth T; Wei B; McKinley TJ; Maskell D; Gay N; Bryant C
    J Immunol; 2008 Jul; 181(2):1245-54. PubMed ID: 18606678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D: The unexplored immunomodulator.
    Das BK; Panda AK
    Int J Rheum Dis; 2016 Apr; 19(4):332-4. PubMed ID: 27122195
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.
    Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP
    Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells.
    Allam JP; Peng WM; Appel T; Wenghoefer M; Niederhagen B; Bieber T; Bergé S; Novak N
    J Allergy Clin Immunol; 2008 Feb; 121(2):368-374.e1. PubMed ID: 18036651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical development of AS04.
    Garçon N
    Methods Mol Biol; 2010; 626():15-27. PubMed ID: 20099118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
    Lien E; Means TK; Heine H; Yoshimura A; Kusumoto S; Fukase K; Fenton MJ; Oikawa M; Qureshi N; Monks B; Finberg RW; Ingalls RR; Golenbock DT
    J Clin Invest; 2000 Feb; 105(4):497-504. PubMed ID: 10683379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations.
    Anderson RC; Fox CB; Dutill TS; Shaverdian N; Evers TL; Poshusta GR; Chesko J; Coler RN; Friede M; Reed SG; Vedvick TS
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):123-32. PubMed ID: 19748238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
    Rostamian M; Niknam HM
    Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models.
    Achek A; Kwon HK; Patra MC; Shah M; Hong R; Lee WH; Baek WY; Choi YS; Kim GY; Pham TLH; Suh CH; Kim W; Hahm DH; Choi S
    EBioMedicine; 2020 Feb; 52():102645. PubMed ID: 32014819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.